Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 15.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.50
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

24 Jul 2014 15:28

RNS Number : 2704N
Biome Technologies PLC
24 July 2014
 



 

24 July 2014

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update, ahead of its interim results for the six-month period ended 30 June 2014, which are expected to be announced on 3 September 2014.

 

Trading Update

 

Total Group revenues achieved for the second quarter of 2014 were £1.2m (Q1 2014: £1.1m; Q2 2013: £0.5m). The turnover for the second quarter maintains the significant progress made in the first quarter of 2014 compared to the same period in the prior year and means that revenues generated by the Group in the first half of 2014 at £2.3m are now in excess of those for the full year of 2013.

 

The Group's cash position at 30 June 2014 was £3.1m (31 March 2014: £3.2m).

 

The business continues to make good progress with the strategy to commercialise and develop wholly owned intellectual property. Performance in the first half was ahead of the Board's expectations for both divisions.

 

Bioplastics Division

 

Q2 2014 revenues for the Bioplastics Division were £0.6m (Q1 2014: £0.5m; Q2 2013: £0.1m) 21% ahead of Q1 2014 performance. Revenues generated by the Bioplastics Division in the first half of 2014 were therefore £1.1m, already in excess of the £1.0m full year 2013 revenue.

 

The focus of the division on developing high margin, application led bioplastic polymers with enhanced level of functionality is starting to take hold. Increasing volumes of Biome's materials were procured in the period for use in the US single-serve coffee market amongst other applications. Further progress was made in the development of the pipeline of new products with technical and customer trials continuing in both the food service and paper-board coating sectors.

 

The division announced the successful completion of a feasibility study undertaken in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining and supported by the Government-backed Technology Strategy Board (TSB).

 

Stanelco RF Technologies Division

 

Q2 2014 revenues for the RF Division were £0.6m (Q1 2014: £0.6m; Q2 2013: £0.4m) maintaining the promising start that the division made in the first quarter of the year. Revenues for the first half of 2014 were £1.2m and are now in excess of the revenues achieved by this division for the full year 2013.

 

Activity and ordering levels in the first half have been encouraging with some evidence that the market for fibre optic furnaces, one of the main repeating products for the division, is experiencing some recovery in Asia. The contract with a customer from a regulated industry has commenced and receipts of approximately one quarter of contract value were received during the first half of 2014. Enquiry and order levels for the business are robust.

 

Group Outlook

 

The Group's revenues and cash are slightly ahead of the Board's expectations at the mid-year point with the reporting of the interim results scheduled for 3 September 2014.

 

This has been a positive first half for the Group and the Board is confident that this progress can be maintained for the full year.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

David Hart (Nominated Adviser)

Mark Treharne (Broker)

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

Allenby Capital

Chris Crawford/Kelly Gardiner

www.allenbycapital.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKQDBQBKDOOB
Date   Source Headline
18th Jul 20137:00 amRNSInterim Management Statement
20th Jun 20132:34 pmRNSIssue of Equity
20th Jun 201312:45 pmRNSResult of General Meeting
17th Jun 201312:01 pmRNSHolding(s) in Company
17th Jun 201311:59 amRNSHolding(s) in Company
23rd May 20137:01 amRNSCapital Reorganisation
23rd May 20137:00 amRNSSettlement with Landlord in Respect of Leases
26th Apr 20137:00 amRNSIssue of shares to a Director Total Voting rights
25th Apr 20134:10 pmRNSResult of AGM
25th Apr 20137:00 amRNSTrading Update
4th Apr 20137:00 amRNSResearch Grant Award
3rd Apr 20134:35 pmRNSNotice of AGM and Annual Report and Accounts
28th Mar 20137:10 amRNSDirector's Remuneration and Consultancy agreement
28th Mar 20137:01 amRNSPreliminary Results
23rd Jan 20137:00 amRNSPre-close Trading Statement
2nd Nov 20127:00 amRNSTrading Update
1st Oct 20123:24 pmRNSCompletion of Sale
27th Sep 20122:03 pmRNSResult of General Meeting
7th Sep 20127:00 amRNSProposed Sale of stake in Biotec Holding GmbH
3rd Sep 20127:00 amRNSInterim Results
29th Aug 20127:00 amRNSPrototype Delivery for Stanelco RF Technologies
19th Jul 20127:00 amRNSInterim Trading Statement
17th Jul 20127:00 amRNSFinancing and Loan Repayment
12th Jul 20127:00 amRNSPatent Litigation Update
10th Jul 20124:40 pmRNSSecond Price Monitoring Extn
10th Jul 20124:35 pmRNSPrice Monitoring Extension
19th Jun 20127:00 amRNSLoan Facility Extension/Directorate Change
31st May 20127:00 amRNSTrading Update
15th May 20124:40 pmRNSSecond Price Monitoring Extn
15th May 20124:35 pmRNSPrice Monitoring Extension
25th Apr 20121:35 pmRNSResult of AGM
25th Apr 20127:00 amRNSTrading Update
4th Apr 20127:00 amRNSNotification of Award under the Public Equity Plan
29th Mar 20127:00 amRNSPreliminary Results
19th Jan 20127:00 amRNSPre-close Trading Statement
10th Jan 20127:00 amRNSContract for RF Technologies Business
16th Dec 20111:27 pmRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSLoan Reclassification
4th Nov 20117:00 amRNSTrading Update
21st Oct 20114:35 pmRNSPrice Monitoring Extension
19th Sep 20117:00 amRNSSector Reclassification
1st Sep 20117:01 amRNSDirectorate Changes
1st Sep 20117:00 amRNSInterim Results
16th May 201111:07 amRNSDirector/PDMR Shareholding
9th May 20117:00 amRNSDirector/PDMR Shareholding
5th May 20112:28 pmRNSResult of AGM
5th May 20117:00 amRNSTrading Update
12th Apr 201112:22 pmRNSHolding(s) in Company
28th Mar 20114:23 pmRNSAnnual Report &Accounts for 2010 and Notice of AGM
24th Mar 20117:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.